Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Exploring the Long-Term Safety and Side Effects of Ashwagandha Supplementation

This discussion delves into the potential long-term safety concerns of ashwagandha, highlighting known short-term effects, rare liver injury cases, and the need for further research on its prolonged use. It advises those with certain health conditions to use caution.


  • long term safety of ashwaganda

  • The long-term safety of ashwagandha, an Ayurvedic herb, remains somewhat uncertain. Here's a summary of the current understanding based on available research:

    1. Short-term Use: Ashwagandha is generally considered safe for use up to three months. Side effects reported in the short term include mild gastrointestinal issues such as stomach upset, diarrhea, and vomiting12.

    2. Liver Concerns: Some rare cases of liver injury have been reported in association with ashwagandha use. These cases presented with symptoms like jaundice and occurred within weeks of starting supplementation. The liver injuries were primarily reported when using commercial herbal products identified as containing ashwagandha34.

    3. Clinical Trials: A few studies, such as one assessing a 4-week use of ashwagandha in healthy males, showed no adverse effects, suggesting short-term safety5. However, extensive research into long-term effects over months or years is lacking46.

    4. Potential Risks: It's also advised that people with specific conditions, such as liver issues, thyroid problems, or those who are pregnant or nursing, approach ashwagandha use with caution due to potential interactions or intensified risks4.

    Overall, while ashwagandha is widely used and believed to be safe for short-term use, the lack of comprehensive long-term safety data suggests caution. Future studies are required to establish its safety profile over longer durations46.

    Footnotes

    1. MedlinePlus

    2. Office of Dietary Supplements

    3. NCBI - LiverTox

    4. Vidyadhar G. Vaidya 2 3 4

    5. K. Chandrasekhar

    6. Deepak Langade 2

Browse Related Questions

Back to top